Want to see DXCM full AI Analyst Report?
Dexcom (DXCM) Income Statement
Dexcom Income Statement
Last quarter (Q3 2026), Dexcom's total revenue was $1.34B, an increase of 11.18% from the same quarter last year. In Q3, Dexcom's net income was $275.10M. See Dexcom’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 4.66B | $ 4.03B | $ 3.62B | $ 2.91B | $ 2.45B | |
| $ 2.80B | $ 2.44B | $ 2.29B | $ 1.88B | $ 1.68B | |
| $ 1.89B | $ 1.84B | $ 1.69B | $ 1.49B | $ 1.41B | |
| Depreciation and Amortization | $ 251.80M | $ 217.70M | $ 186.00M | $ 155.90M | $ 102.00M |
| $ 1.36B | $ 945.70M | $ 916.70M | $ 565.30M | $ 377.60M | |
| $ 911.80M | $ 600.00M | $ 597.70M | $ 391.20M | $ 265.80M | |
| $ 176.60M | $ 109.00M | $ 112.70M | $ -400.00K | $ -9.00M | |
| $ 1.09B | $ 709.00M | $ 710.40M | $ 390.80M | $ 256.80M | |
| $ 836.30M | $ 576.20M | $ 541.50M | $ 341.20M | $ 216.90M | |
| Per Share Metrics | |||||
| Basic EPS | $ 2.14 | $ 1.46 | $ 1.44 | $ 0.88 | $ 0.56 |
| Diluted EPS | $ 2.09 | $ 1.42 | $ 1.30 | $ 0.80 | $ 0.51 |
| Weighted Average Shares Outstanding | 390.20M | 404.63M | 386.00M | 389.40M | 386.90M |
| Weighted Average Shares Outstanding (Diluted) | 405.50M | 412.70M | 425.50M | 427.50M | 428.80M |
Currency in USD